LogicBio Therapeutics, Inc.
LOGC
|
$2.07
-0.48%
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (-0.5% 7d) (NaN% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 68,232,857
http://www.logicbio.com
Sec Filling | Patents | 41 employees
(US) LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Cambridge, MA.
genomic genome editing
add to watch list Paper trade email alert is off
Press-releases
Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daphne Karydas
Published: 2023-09-14 (Crawled : 20:00) - globenewswire.com
MLYS M | $11.32 5.3% 5.04% 100K
|
|
| O: 0.25%
H: 1.34%
C: -3.92%
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: 0.09%
H: 0.95%
C: -1.12%
FOLD F | $10.62 2.81% 2.73% 2.5M
|
Health Technology
|
| O: 0.0%
H: 0.95%
C: -0.15%
therapeutics
Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics
Published: 2022-11-16 (Crawled : 14:00) - biospace.com/
LOGC | $2.07 -0.48%
|
Health Technology
| Email alert
Add to watchlist
logicbio acquisition rare therapeutics
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
Published: 2022-11-14 (Crawled : 15:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -1.95%
H: 1.58%
C: 0.96%
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: 0.0%
logicbio therapeutics financial results
INVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of LogicBio Therapeutics, Inc. - LOGC
Published: 2022-10-04 (Crawled : 03:00) - prnewswire.com
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: 0.0%
logicbio
LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONE
Published: 2022-09-21 (Crawled : 13:00) - biospace.com/
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: 2.06%
H: 0.86%
C: -10.66%
lb-001 logicbio pre-clinical therapeutics one
LogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-15 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.63%
H: 0.85%
C: 0.56%
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: -4.76%
H: 3.33%
C: -14.17%
therapeutics update results
BioSpace Movers & Shakers: Evommune, Maravai, Aptose & More
Published: 2022-07-01 (Crawled : 13:20) - biospace.com/
WAT | $296.1 0.64% 0.0% 470K
|
Health Technology
|
| O: 0.24%
H: 1.75%
C: 1.54%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: 1.78%
H: 5.78%
C: -3.38%
MDWD | $15.9 -6.42% -6.86% 110K
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: -3.24%
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: -5.41%
H: 17.14%
C: 13.29%
DVAX | $11.78 3.88% 3.74% 9.3M
|
Health Technology
|
| O: -0.32%
H: 3.98%
C: 3.27%
AKBA | $1.36 -2.16% -2.21% 2.9M
|
Health Technology
|
| O: 39.88%
H: 0.22%
C: -21.24%
Zentalis Pharmaceuticals Appoints Andrea Paul as General Counsel and Corporate Secretary
Published: 2022-06-27 (Crawled : 12:20) - biospace.com/
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: -1.06%
H: 3.74%
C: 0.11%
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: 2.3%
H: 2.22%
C: -3.29%
AKBA | $1.36 -2.16% -2.21% 2.9M
|
Health Technology
|
| O: 0.55%
H: 3.65%
C: 1.91%
LogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business Updates
Published: 2022-05-16 (Crawled : 13:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: 10.3%
H: 5.66%
C: -2.27%
therapeutics results
LogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual Meeting
Published: 2022-05-11 (Crawled : 14:00) - biospace.com/
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: -2.54%
H: 5.94%
C: -11.7%
therapeutics
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10